University of Virginia, Newborn Intensive Care Unit
Charlottesville, Virginia, 22932, United States
NCT Number: NCT01729000
The purpose of this study is to compare the additional use of gloves (with handwashing before and after gloving) for all patient contact while infants have intravenous (central or peripheral) access in a RCT. Preterm infants <1000 grams or less than 29 weeks gestational age will be randomized after birth to either a handwashing-gloving group or handwashing only group. The primary outcome will be the incidence of invasive infections (bacterial or fungal) or necrotizing enterocolitis. Secondary outcomes will include hospital days, preterm morbidities, mortality, and hospital costs.
Looking for future studies?
Notify MeUp to 8 day
All sexes
Interventional
Not applicable
Charlottesville, Virginia, 22932, United States
All infants who had a birth weight of less than or equal to 1000 grams or who were born less than 29 weeks gestation were eligible for this study. 120 subjects were randomized by day of life(dol) 8 to one of two study groups--hand hygiene or hand hygiene plus gloving. Study signs were placed at the bedside and on the isolette sides of each infant with the appropriate study group guidelines.
The investigators goal was to target the time period these infants are at high-risk for infection or NEC and its associated mortality. The targeted time was the first 4 weeks of life or longer while intravenous access is still required. The average age for the first episode of late-onset sepsis is 22(+/-0.5) days (median: 17 days; 75th percentile: 28 days; 95th percentile: 57 days). The majority of infections that occur after 4 weeks of life are in patients still requiring IV access (peripheral or central). The presence of an intravenous line in this group of preterm infants correlates with the presence of risk factors for infection that would necessitate the need for intravenous access including: parenteral nutrition, lipid infusion, use of broad spectrum antibiotics, and the intravenous line itself (if it is a central venous catheter). This strategy focused on the individual infant's risks, limits exposure to and decreases cost of intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All staff must wear gloves for subjects that are in the experimental group.
Time frame: Participants will be followed during their NICU hospitalization, an expected average of 3 months
Invasive infection will be defined as growth of bacteria from culture (blood, urine, CSF, peritoneal) with clinical signs and symptoms of sepsis
Time frame: Participants will be followed for their entire NICU hospitalization, which is an average of 3 months
NEC will be defined as stage II or greater using Bell's modified criteria
Time frame: Participants will be followed for their entire NICU hospitalization, which is an average of 3 months
Length of stay will be compared in each study arm
Time frame: Participants will be followed for their entire NICU hospitalization, which is an average of 3 months
Mortality will be compared in each study arm
Time frame: Participants will be followed for their entire NICU hospitalization, which is an average of 3 months
Hospital costs will be compared in each study arm
Time frame: Participants will be followed for their entire NICU hospitalization, which is an average of 3 months
Common morbidities will be compared in each study arm
University of Virginia
Other
Gloving and Handwashing to Prevent Invasive Infections in Necrotizing Enterocolitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04718220
COVID-19, Coronaviridae Infections
St Louis, Missouri, United States
View Trial DetailsNCT04955717
Bacterial Infections, Bacterial Infections and Mycoses
Los Angeles, California, United States
View Trial DetailsNCT06413056
Bacterial Infections and Mycoses, Female Urogenital Diseases and Pregnancy Complications
Cairo, Abbassia, Egypt
View Trial DetailsNCT04200807
Female Urogenital Diseases and Pregnancy Complications, Neonatal Infection
Vilnius, Lithuania
View Trial Details